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ABSTRACT Three-dimensional structures of only a handful of membrane proteins have been solved, in contrast to the
thousands of structures of water-soluble proteins. Difficulties in crystallization have inhibited the determination of the
three-dimensional structure of membrane proteins by x-ray crystallography and have spotlighted the critical need for
alternative approaches to membrane protein structure. A new approach to the three-dimensional structure of membrane
proteins has been developed and tested on the integral membrane protein, bacteriorhodopsin, the crystal structure of which
had previously been determined. An overlapping series of 13 peptides, spanning the entire sequence of bacteriorhodopsin,
was synthesized, and the structures of these peptides were determined by NMR in dimethylsulfoxide solution. These
structures were assembled into a three-dimensional construct by superimposing the overlapping sequences at the ends of
each peptide. Onto this construct were written all the distance and angle constraints obtained from the individual solution
structures along with a limited number of experimental inter-helical distance constraints, and the construct was subjected to
simulated annealing. A three-dimensional structure, determined exclusively by the experimental constraints, emerged that
was similar to the crystal structure of this protein. This result suggests an alternative approach to the acquisition of structural
information for membrane proteins consisting of helical bundles.
INTRODUCTION
Determination of membrane protein structure has proven a
more difficult subject than the determination of soluble
protein structure due to the hydrophobic nature of mem-
brane proteins and their resulting insolubility in aqueous
medium. Crystals suitable for diffraction studies are diffi-
cult to obtain for these proteins. Much effort has been
invested in growing both two-dimensional and three-dimen-
sional crystals to enable diffraction studies. However, be-
cause progress is still slow on the determination of mem-
brane protein structures, alternative approaches to structure
would be helpful.
A growing body of data suggests that solution structures
of peptides derived from some classes of proteins retain the
secondary structure of the parent protein because of the
dominance of short-range interactions that can be captured
in peptides. Studies on segments of proteins forming -he-
lices show that peptides containing these sequences form
-helices in almost every case (Gao et al., 1999; Ramirez-
Alvarado et al., 1997; Gegg et al., 1997; Hamada et al.,
1995; Callihan and Logan, 1999; Wilce et al., 1999; Jime-
nez et al., 1999; Fan et al., 1998; Cox et al., 1993; Hunt et
al., 1997). Peptides representing segments that are turns in
the native protein also show turns as peptides in solution
(Chandrasekhar et al., 1991; Ghiara et al., 1994; Blumen-
stein et al., 1992; Blanco and Serrano, 1994; Goudreau et
al., 1994; Adler et al., 1995; Campbell et al., 1995; Wilce et
al., 1999; Cox et al., 1993; Katragadda et al., 2000). Both
-helices and turns are dominated by short-range interac-
tions (Yang et al., 1996a). In some cases, the sequence of an
entire protein, built around helical bundles, has been incor-
porated in a series of peptides spanning that sequence, and
the individual peptides have reported the secondary struc-
ture of the native proteins with fidelity (Blanco and Serrano,
1994; Behrends et al., 1997; Reymond et al., 1997; Dyson et
al., 1992; Padmanabhan et al., 1999).
It might therefore be hypothesized that peptides contain-
ing the amino acid sequences for turns or for transmem-
brane helices of membrane proteins built of helical bundles
will exhibit the same secondary structures in solution that
those sequences adopt in the native protein. This hypothesis
could provide access to important structural information for
a transmembrane protein that may be available from no
other approach.
Bacteriorhodopsin from Halobacteria offers an excellent
opportunity to examine this hypothesis. The structure of
bacteriorhodopsin consists of a bundle of seven transmem-
brane helices connected by turns. Engelman and co-workers
have found that the transmembrane helices of this protein
are independently stable folding units (Hunt et al., 1997)
and thus can be considered protein domains (Popot and
Engelman, 2000). Several x-ray crystal structures are avail-
able for this membrane protein (Gouaux, 1998; Grigorieff et
al., 1996; Luecke et al., 1999; Pebay-Peyroula et al., 1997).
We synthesized a series of overlapping peptides spanning
the sequence of bacteriorhodopsin and determined the so-
lution structures of these peptides using NMR in dimethyl-
sulfoxide (DMSO) solution. The solution structures of these
peptides compared favorably with the corresponding re-
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gions of the x-ray crystal structure. These individual peptide
structures, and the constraints obtained for them, were then
used to build the three-dimensional structure for the whole
protein by a new method. The resulting structure was sim-
ilar to structures determined from electron and x-ray dif-
fraction data.
MATERIALS AND METHODS
Peptide synthesis
Peptides were synthesized through solid-phase synthesis in the Biotech-
nology Center of the University of Connecticut. Synthesis was performed
on an Applied Biosystems 433A peptide synthesizer, using fastMoc chem-
istry on HMP resin at room temperature. HBTU was used for activation
and the column was washed with NMP. The N- and C-termini were not
capped.
NMR spectroscopy
All NMR spectra were recorded on a Bruker AMX-600 spectrometer at
30°C in DMSO. Standard pulse sequences and phase cycling were em-
ployed to record double quantum filtered (DQF) COSY, TOCSY, and
NOESY (Kumar et al., 1980) (data were collected with 400-ms mixing
times). Previous work with other similar-sized peptides at mixing times of
150, 250, and 400 ms showed no evidence of spin diffusion and 400 ms
showed the most useful interactions in the NOESY. All spectra were
accumulated in a phase-sensitive manner using time-proportional phase
incrementation for quadrature detection in F1. All the data for the structure
determinations were obtained in DMSO at 25°C or 30°C. Chemical shifts
were referenced to the residual protons in the d6-DMSO. DMSO was
chosen as a solvent only because it was one solvent system in which both
the loop peptides (which are insoluble in water) and the transmembrane
helix peptides were soluble. Some helices and turns were not soluble in
detergent micelles. (Another solvent system consisting of CDCl3/CD3OD/
D2O has been used successfully for a pair of hydrophobic helices con-
nected by a turn (Dmitriev et al., 1999).) The torsion angle constraints ()
were obtained from the coupling constants measured as described (Lud-
vigsen et al., 1991) using the program PRONTO (written by M. Kjaer).
Structure refinement
The sequence-specific assignment of the 1H NMR spectrum for each
peptide was carried out using standard methods employing FELIX (MSI,
San Diego, CA). Assigned NOE cross-peaks were segmented using a
statistical segmentation function and characterized as strong, medium, and
weak corresponding to upper bounds distance range constraints of 2.7, 3.5,
and 5.0 Å, respectively. Lower bounds between nonbonded atoms were set
to the sum of their van der Waals radii (1.8 Å). Pseudo-atom corrections
were added to inter-proton distance restraints where necessary (Wu¨thrich et
al., 1983). Structures were obtained using simulated annealing with these
experimental distance constraints from the NOESY data and the torsion
angle constraints obtained from the COSY data. The Kollman All Atom
force field and Kollman charges were used within Sybyl (Tripos, St. Louis,
MO). The molecule was heated to 800 K for 1000 fs followed by cooling
to 200 K during 1500 fs. Five or ten consecutive cycles were calculated.
These calculations were performed on a Silicon Graphics R10000 com-
puter.
Assembly of the peptide fragments
A construct for the whole protein can be assembled from the pieces whose
individual structures are determined as described above. Because of the
design of the set of peptides, the overlap in the sequences of these peptides
can be superimposed. The superposition was done with recognition of the
disordering that is typically observed at the ends of the peptide. Taking
advantage of the 10-residue overlap, the most disordered residues were not
used in the superposition algorithm. The unused residues were discarded
from the file. The construct then consists of the structures of all the
peptides with the overlapping sequences. A model of helix G (because an
NMR structure could not be obtained for this peptide) was temporarily
added to the construct to be used as an anchor point for some of the
inter-helical distances to adequately pack the transmembrane helical bun-
dle of bacteriorhodopsin. In the final structure, helix G was removed
because its structure could not be determined experimentally. Retinal was
not included in this structure, because it is bound to helix G. Redundant
sequences are then removed from the Protein Data Bank file. To test the
limits of this approach, another construct was assembled, by first super-
imposing the experimental peptide helical structures on the corresponding
helices of one of the structures (1brd, 7 Å resolution), removing the crystal
structure, and then adding the loop peptide structures by simultaneously
superimposing both ends of the loop structure onto the ends of the appro-
priate transmembrane helices. The ultimate result using this construct, after
the simulated annealing (see below), was similar to the result using the first
construct, with a somewhat improved match to the crystal structures.
Simulated annealing
On the construct, all the distance range constraints and dihedral angle
constraints obtained from the solution structures of each of the peptides
were written in a mol2 file with SYBYL (Tripos). To this were added
inter-helical distance constraints derived from intermediate-resolution elec-
tron diffraction studies (Henderson et al., 1990) to define the packing of the
helical bundle. These constraints consist of distances (as range constraints)
between the tops of pairs of helices in the transmembrane bundle as well
as between the middle and the bottom of pairs of helices of the bundle (see
Table 2). Hydrogen bond constraints were added where hydrogen bonds
were observed in the original solution structures of the peptides. A simu-
lated annealing protocol was used to fold a structure that was consistent
with the available experimental distance constraints. The construct for
bacteriorhodopsin was heated to 800°C for 1000 fs and then cooled for
1500 fs to 200°C. The Kollman All Atom force field and Kollman charges
were used within Sybyl. The process of simulated annealing, with all the
NOE-derived distance constraints on all parts of the molecule, at one point
led to a distortion of one of the helical segments (helix C) so that its
structure differed from the original structure observed in the solution NMR
of the individual peptide. As a refinement process, we selected a few
appropriate inter-atomic distances on that distorted segment, measured
those inter-atomic distances on the original NMR solution structure, and
added those as distance constraints to the construct of the whole molecule.
After another simulated annealing, the structure of that particular helix
once again was close to the structure observed in the original solution
structure of the peptide. These calculations were performed on a Silicon
Graphics R10000 computer.
RESULTS AND DISCUSSION
Three-dimensional structures of the set of
overlapping peptides spanning the sequence of
rhodopsin
A set of peptides was designed for the complete primary
sequence of bacteriorhodopsin. Fig. 1 shows the sequences
of these peptides. Each peptide was designed to encompass
either a transmembrane helix of the protein or a turn.
Peptides containing a turn also included some of the helices
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(one to two turns) that connect to the turn on both sides.
Peptides containing a turn that was shorter (15–17 residues)
than the ones used here usually showed in the solution
structure only the turn with no information on how that turn
connected to the transmembrane helices. Therefore we
moved to longer peptides from which one might expect (and
usually got) a helix-turn-helix motif. Furthermore, each
peptide was designed to overlap each of its neighbors in the
series by 10 amino acids. The overlap was necessary be-
cause structures of peptides in solution typically show ill-
defined termini. To obtain structural information on the
entire sequence thus necessitated a design in which the
disordered ends of each of the peptides could be ignored.
After trying shorter overlaps, we found that a 10-amino-acid
overlap is probably minimal. Each of the overlap regions
turned out to be helical and to have enough structure to
perform a superposition to connect the two structures re-
quired a minimum of four to five residues that were well
defined and in a helical conformation. Because the last two
to four residues of peptides are frequently disordered in
solution, the overlap region needs to be 8–13 amino acids
long. In most cases, an overlap of 10 residues worked well.
The structures of these peptides could most easily be
obtained in solution by NMR. To do so, a common solvent
was required. Most of the peptides in this set from bacte-
riorhodopsin were hydrophobic and not soluble in water.
Although some peptides (coding for transmembrane heli-
ces) were soluble in detergent micelles (Hunt et al., 1997),
peptides coding for loops were not soluble in detergent
micelles in a manner that preserved structure as measured
by circular dichroism. All peptides in the series were soluble
in DMSO except for the peptide corresponding to helix G,
which was not soluble in DMSO or in chloroform/methanol
solutions. Previous work had shown that helix G was not
stable in detergent micelles either (Hunt et al., 1997) (how-
ever, helix G was stable in organic solvent when part of a
peptide that included helix F as well (Barsukov et al.,
1992)). Previous studies had shown that peptides encoding
three loops of bacteriorhodopsin were not only soluble in
DMSO but also exhibited the same structure in solution in
DMSO as the same sequences adopted in the crystal struc-
ture of the intact protein (Katragadda et al., 2000). DMSO
was therefore chosen as a solvent that could be used in
common for the 12 of the 13 peptides.
The structures of these 12 peptides in solution were
determined by two-dimensional homonuclear 1H NMR as
described in detail previously (Yeagle et al., 1997, 1995;
Katragadda et al., 2000). Details of the structure determi-
nation for three of the loops were described previously
(Katragadda et al., 2000). Details of two of the helices, helix
A and helix C, are presented here as examples, including the
number of constraints per residue (Fig. 2), the connectivities
FIGURE 1 Sequences of overlapping peptides from bacteriorhodopsin
used in this study. These peptides were synthesized by solid-phase peptide
synthesis as described previously (Katragadda et al., 2000). The tubes show
the approximate extent of the helical regions in the crystal structure, which
are labeled A through G. Overlaps in sequences of the peptides are
indicated by overlaps of the representations of the peptides in the figure.
FIGURE 2 Numbers of constraints (per residue) obtained from the
NOESY data for the peptides from helix A and from helix C. Black bar,
intra-residue constraints; horizontal hatched bar, sequential constraints;
diagonal hatched bar, long-range constraints.
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from the NOE data (Fig. 3), and the families of structures
superimposed (Fig. 4). These are similar to results from
solution NMR of helices from other membrane proteins
(Chopra et al., 2000). Table 1 describes the constraints used
in the structure determinations for these peptides. These
include distance constraints from NOESY data and torsion
angle constraints () from COSY data. Each of the 12
peptides exhibited one family of structures in solution.
Families of structures were calculated from the constraints.
Good overlap of the members of the family was observed
over most of the sequence. The ends of each of the peptides
were disordered as expected for peptide structures. Table 1
shows the average pair-wise rmsd of the families of struc-
tures. Table 1 also indicates which residues were in the
well-ordered regions of the structures.
Peptides from the loop regions CD, DE, and FG of
bacteriorhodopsin formed loops in solution (Katragadda et
al., 2000). Fig. 2 shows that the other three peptides corre-
sponding to loops of bacteriorhodopsin also formed loops in
solution. Furthermore, peptides corresponding to helices A,
B, C, D, E, and F of bacteriorhodopsin formed helices in
solution. This is in agreement with previous studies that
showed a helical structure in organic solvent and/or deter-
gent micelles for peptides of helix B, helices A  B, and
helices F  G (Lomize et al., 1992; Barsukov et al., 1992;
Pervushin et al., 1994).
FIGURE 3 Connectivities observed in the NOESY data for the peptides
from helix A and from helix C.
FIGURE 4 Families of structures obtained for the peptides from helix A
and from helix C. Six structures are superimposed for each peptide in this
representation.
TABLE 1 Summary of data for peptide structures
Peptide Length
Number
of NOE
constraints
Number
of angle
constraints
RMSD
of the
family
Well
ordered
residues
Helix A 25 223 5 0.75 2–24
Loop AB 32 263 2 1.7 10–30
Helix B 25 213 4 1.9 3–20
Loop BC 28 269 4 2.5 7–22
Helix C 27 246 5 1.1 6–25
Loop CD 23 156 3 1.2 2–21
Helix D 23 196 5 1.6 3–19
Loop DE 15 168 0 0.8 2–13
Helix E 32 311 2 1.5 2–30
Loop EF 22 192 2 1.2 3–20
Helix F 32 280 6 1.6 10–30
Loop FG 24 163 3 0.9 2–21
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Comparison of peptide structures to crystal
structure of bacteriorhodopsin
Fig. 2 also shows the superposition of the structures of these
peptides on the corresponding portions of one of the crystal
structures. The peptides corresponding individually to heli-
ces A through F from bacteriorhodopsin each form a helix
that mimics the crystal structure. The peptides correspond-
ing to all six turns from bacteriorhodopsin form turns with
the same residues in both the crystal structure and the
peptide. Most of these peptide structures superimpose on the
crystal structure with an average backbone rmsd less than
2.5 Å (see inset), indicating that the structures in the pep-
tides are similar to the crystal structure (given the limited
number of constraints available from NMR from modest-
sized peptides in solution) (Katragadda et al., 2000). For
comparison, the overall backbone rmsd between two crystal
structures of bacteriorhodopsin (2BRD and 1AP9) is 2.3.
Analysis of the B factors from the crystal structures
shows that the electron densities of loops AB, BC, and EF
are not well defined in the available crystal structures.
Because of these limitations, it is not possible to quantita-
tively compare the structures of these peptides to the struc-
tures of the corresponding loops in the crystal structure.
Therefore, there are blank regions in the plot inset in Fig. 2.
Nevertheless, the residues that populate the turns in the
crystal structures and in the peptides are the same.
These data indicate that most of the secondary structure
of bacteriorhodopsin can be accurately captured in this
series of overlapping peptides that span the sequence of the
protein. This information is useful in determining the start
and stop points of helices, whether the helices are straight or
bent, and which residues are in the turns that connect the
transmembrane helices. Some suggestion of the ability to
get such information on secondary structure has been ob-
served previously for another protein. Work on rhodopsin,
also consisting of a bundle of seven transmembrane helices,
FIGURE 5 -Carbon maps of the superposition of the backbone atoms
of the peptide structures on the corresponding sequences in one crystal
structure (2BRD) of bacteriorhodopsin. In each case, one member of the
family of peptide structures, randomly chosen, was superimposed on the
crystal structure. Similar results were obtained from superposition of these
peptide structures on 1AP9. The superpositions were calculated using only
the well-ordered portions of the peptide structures, as listed in Table 1.
(Inset) The rmsd (Å) of the superposition is plotted for each peptide as a
function of the sequence of bacteriorhodopsin. The horizontal line repre-
sents the average rmsd of superposition of 2BRD on 1AP9.
FIGURE 6 Three-dimensional structure of bacteriorhodopsin deter-
mined as described in this work. (A) Five structures obtained from simu-
lated annealing as described in the text superimposed on each other, with
the non-experimental part of helix G removed. (B) One of the structures
from A (red) superimposed on one of the crystal structures (green) of
bacteriorhodopsin (2brd).
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showed that the stop point of helix 5 in the third cytoplasmic
loop determined from the structure of a peptide (Yeagle et
al., 1997) was the same as had been identified from spin-
label experiments on intact rhodopsin (Yang et al., 1996b)
(the stop point of this helix cannot be determined from the
recent crystal structure of rhodopsin due to the high B
factors (Palczewski et al., 2000)). Likewise, the stop point
of helix 7 determined from peptide structure (Yeagle et al.,
2000) was the same as identified from spin-label experi-
ments on intact rhodopsin (Altenbach et al., 1999) and the
same as in the recent crystal structure of rhodopsin (Palc-
zewski et al., 2000).
Use of peptide structures to determine the three-
dimensional structure of bacteriorhodopsin
Exploiting the overlap of adjacent peptides, a continuous
construct (residues 1–203) of all the peptides can be made
by superimposing the backbone atoms of the overlapping
sequences. All available experimental distance constraints
were then written on this construct, including 2681 distance
range constraints and 41 angle constraints from the NMR
data on the individual peptides. As described below, some
inter-helical distance constraints were used in this structure
determination to help organize the helical bundle, and they
were obtained from 1brd, a 7-Å-resolution diffraction study
of two-dimensional crystals of bacteriorhodopsin (Hender-
son et al., 1990). We determined inter-helical distances
between pairs of helices at the top, middle, and bottom, and
assigned top, for example, to a residue near the top of the
helix in our solution structure. These inter-helical distances
had to be converted to distances between specific -carbons
of specific residues to be included in the constraint list for
simulated annealing. This conversion was performed by
taking into account the differences between a center-to-
center distance for two helices and the distances between
atoms on the two helices that are not at the helical center.
The distances are range constraints to account for the un-
certainties in this procedure (Table 2). Alternatively, the
necessary constraints can be obtained from a variety of
measurements, including solid-state NMR experiments (ro-
tational resonance), cysteine scanning (disulfide bond for-
mation), dipolar interactions between spin labels, fluores-
cence energy transfer measurements, engineering of metal
binding sites, or complementary mutagenesis experiments.
Simulated annealing is used to optimize the conformation
of the construct with respect to all the experimental con-
straints simultaneously. The result is shown in Fig. 3 as a
family of structures with an average pair-wise backbone
rmsd of 1.55. Fig. 3 also shows an overlay of this structure
on a previously determined crystal structure of bacteriorho-
dopsin. The rmsd of simultaneous superposition of all the
helices of the current structure on 2brd is 2.9 (the B factors
from x-ray and electron diffraction studies are high in the
loops, thus limiting quantitative comparisons to the trans-
membrane helical bundle with much lower B factors).
Somewhat poorer superpositions result if 1ap9 or 1c3w are
used. Thus, considerable agreement between the three-di-
mensional structure determined by the method described
here and the structures determined by electron and x-ray
diffraction is observed.
These results suggest that for transmembrane proteins
built around helical bundles, considerable structural infor-
mation can be obtained from the segmented approach de-
TABLE 2 Inter-helical constraints taken from the electron
diffraction studies of bacteriorhodopsin (1BRD)
Atom 1 Atom 2
Distance
range
Bottom A(THR17) Bottom B(TYR57) 3.1–7.1
Top A(GLY31) Top B(TYR43) 3.4–7.4
Middle A(THR24) Middle B(ALA51) 3.4–7.4
Middle A(MET20) Middle C(ASP85) 9.7–13.7
Top A(GLY31) Top C(ASP96) 12.4–16.4
Bottom C(ILE78) Bottom A(LEU13) 7.3–11.3
Bottom A(LEU13) Bottom D(LEU123) 17.7–21.7
Top A(GLY31) Top D(ILE108) 22–26
Bottom B(SER59) Bottom C(TRP80) 7.8–11.8
Top B(ILE45) Top C(LEU95) 6.2–10.2
Middle B(ILE52) Middle C(PHE88) 5.7–9.7
Top C(LEU95) Top D(LEU109) 7–11
Middle C(LEU87) Middle D(ILE117) 7.4–11.4
Bottom C(TRP80) Bottom D(VAL124) 8.6–12.6
Bottom D(THR121) Bottom E(TRP137) 4.2–8.2
Middle D(ALA114) Middle E(ALA144) 3.9–7.9
Top D(THR107) Top E(VAL151) 6.5–10.5
Top E(PHE156) Top F(LYS172) 5.7–9.7
Middle E(LEU146) Middle F(SER183) 7.1–11.1
Bottom E(PHE135) Bottom F(LEU190) 6–10
Bottom A(GLU9) FG loop(ASN202) 3.7–7.7
Bottom A(TRP12) Bottom F(VAL188) 13.6–17.6
Top A(GLY31) Top F(THR170) 14.6–18.6
Middle A(GLY23) Middle F(VAL177) 15.4–19.4
Bottom B(SER59) Bottom D(VAL124) 18.2–22.2
Top B(ILE45) Top D(LEU109) 14–18
Bottom B(SER59) Bottom E(TRP137) 23.5–17.5
Top B(LYS41) Top E(GLY155) 17.2–21.2
Middle C(LEU84) Middle E(ILE140) 16.7–20.7
Top C(LEU95) Top E(VAL151) 10.7–14.7
Middle C(TYR83) Middle F(PRO186) 10.9–14.9
Top C(LEU94) Top F(ASN176) 11.5–15.5
Top D(LEU111 Top F(ASN176) 15.9–19.9
Bottom D(GLY122) Bottom F(PRO186) 7.3–11.3
Top C(ASP96) Top G(LEU223) 7.3–11.3
Middle C(ASP85) Middle G(ASP212) 8.5–12.5
Bottom C(TYR79) Bottom G(THR205) 7.4–11.4
Top F(PHE171) Top G(LEU223) 6.6–10.6
Middle F(SER184) Middle G(LEU211) 6–10
Bottom F(SER193) Bottom G(LEU201) 3.7–7.7
Bottom A(TRP12) Bottom G(LEU206) 3.4–7.4
Middle A(MET20) Middle G(VAL213) 4.8–8.8
Top A(LEU28) Top G(LEU223) 11.6–15.6
Middle B(PRO50) Middle G(LYS216) 4–8
Top B(PHE42) Top G(LEU223) 5.7–9.7
Bottom B(LEU61) Bottom G(THR205) 8.9–12.9
Distances are -carbon to -carbon (see text).
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scribed in this work. These results offer an alternative
approach to obtain some useful structural information in the
absence of a high-resolution x-ray crystallographic study.
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This work was supported by National Institutes of Health grant EY03328
and in part by CA16056.
REFERENCES
Adler, M., M. H. Sato, D. E. Nitecki, J.-H. Lin, D. R. Light, and J. Morser.
1995. The structure of a 19 residue fragment from the C loop of the
fourth epidermal growth factor-like domain of thrombomodulin. J. Biol.
Chem. 270:23366–23372.
Altenbach, C., K. Cai, H. G. Khorana, and W. L. Hubbell. 1999. Structural
features and light-dependent changes in the sequence 306–322 extend-
ing from helix VII to the palmitoylation sites in rhodopsin: a site-
directed spin-labeling study. Biochemistry. 38:7931–7937.
Barsukov, I. L., D. E. Nolde, A. L. Lomize, and A. S. Arseniev. 206. 1992.
Three-dimensional structure of proteolytic fragment 163–231 of bacte-
rioopsin determined from nuclear magnetic resonance data in solution.
Eur. J. Biochem. 665–672.
Behrends, H. W., G. Folkers, and A. G. Beck-Sickinger. 1997. A new
approach to secondary structure evaluation: secondary structure predic-
tion of porcine adenylate kinase and yeast guanylate kinase by CD
spectroscopy of overlapping synthetic peptide segments. Biopolymers.
41:213–231.
Blanco, F. J., and L. Serrano. 1994. Folding of protein G B1 domain
studied by the conformational characterization of fragments comprising
its secondary structure elements. Eur. J. Biochem. 230:634–649.
Blumenstein, M., G. R. Matsueda, S. Timmons, and J. Hawiger. 1992. A
 turn is present in the 392–411 segment of the human fibrinogen 
chain: effects of structural changes in this segment on affinity to anti-
body 4A5. Biochemistry. 31:10692–10698.
Callihan, D. E., and T. M. Logan. 1999. Conformations of peptide frag-
ments from the FK506 binding protein: comparison with the native and
urea-unfolded states. J. Mol. Biol. 285:2161–2175.
Campbell, A. P., C. McInnes, R. S. Hodges, and B. D. Sykes. 1995.
Comparison of NMR structures of the receptor binding domains of
Pseudomonas aeruginosa Pili strains PAO, KB7, and PAK: implications
for receptor binding and synthetic vaccine design. Biochemistry. 34:
16255–16268.
Chandrasekhar, K., A. T. Profy, and H. J. Dyson. 1991. Solution confor-
mation preferences of immunogenic peptides derived from the principal
neutralizing determinant of the HIV-1 envelope glycoprotein gp120.
Biochemistry. 30:9187–9194.
Chopra, A., P. L. Yeagle, J. A. Alderfer, and A. Albert. 2000. Solution
structure of the sixth transmembrane helix of the G-protein coupled
receptor, rhodopsin. Biochim. Biophys. Acta. 1463:1–5.
Cox, J. P. L., P. A. Evans, L. C. Packman, D. H. Williams, and D. N.
Woolfson. 1993. Dissecting the structure of a partially folded protein. J.
Mol. Biol. 234:483–492.
Dmitriev, O., P. C. Jones, W. Jiang, and R. H. Fillingame. 1999. Structure
of the membrane domain of subunit b of the Escherichia coli F0F1 ATP
synthase. J. Biol. Chem. 274:15598–15604.
Dyson, H. J., G. Merutka, J. P. Waltho, R. A. Lerner, and P. E. Wright.
1992. Folding of peptide fragments comprising the complete sequence of
proteins. J. Mol. Biol. 226:795–817.
Fan, J. S., H. C. Cheng, and M. Zhang. 1998. A peptide corresponding to
residues asp177 to asn208 of human cyclin a forms an alpha helix.
Biochem. Biophys. Res. Commun. 253:621–627.
Gao, J., Y. Li, and H. Yan. 1999. NMR solution structure of domain 1 of
human annexin I shows an autonomous folding unit. J. Biol. Chem.
274:2971–2977.
Gegg, C. V., K. E. Bowers, and C. R. Matthews. 1997. Probing minimal
independent folding units in dihydrofolate reductase by molecular dis-
section. Protein Sci. 6:1885–1892.
Ghiara, J. B., E. A. Stura, R. L. Stanfield, A. T. Profy, and I. A. Wilson.
1994. Crystal structure of the principal neutralization site of HIV-1.
Science. 264:82–85.
Gouaux, E. 1998. It’s not just a phase: crystallization and x-ray structure
determination of bacteriorhodopsin in lipidic cubic phases. Structure.
6:5–10.
Goudreau, N., F. Cornille, M. Duchesne, F. Parker, B. Tocque´, C. Garbay,
and B. P. Roques. 1994. NMR structure of the N-terminal SH3 domain
of GRB2 and its complex with a proline-rich peptide from SOS. Nat.
Struct. Biol. 1:898–907.
Grigorieff, N., T. A. Ceska, K. H. Downing, J. M. Baldwin, and R.
Henderson. 1996. Electron-crystallographic refinement of the structure
of bacteriorhodopsin. J. Mol. Biol. 259:393–421.
Hamada, D., Y. Kuroda, T. Tanaka, and Y. Goto. 1995. High helical
propensity of the peptide fragments derived from -lactoglobulin, a
predominantly -sheet protein. J. Mol. Biol. 254:737–746.
Henderson, R., J. M. Baldwin, T. A. Ceska, F. Zemlin, E. Beckmann, and
K. H. Downing. 1990. Model for the structure of bacteriorhodopsin
based on high-resolution electron cryo-microscopy. J. Mol. Biol. 213:
899–929.
Hunt, J. F., T. N. Earnest, O. Bousche, K. Kalghatgi, K. Reilly, C. Horvath,
K. J. Rothschild, and D. M. Engelman. 1997. A biophysical study of
integral membrane protein folding. Biochemistry. 36:15156–15176.
Jimenez, M. A., J. A. Evangelio, C. Aranda, A. Lopez-Brauet, D. Andreu,
M. Rico, R. Lagos, and J. M. Andreu. 1999. Helicity of alpha(404–451)
and beta(394–445) tubulin C-terminal recombinant peptides. Protein
Sci. 8:788–799.
Katragadda, M., J. L. Alderfer, and P. L. Yeagle. 2000. Solution structure
of the loops of bacteriorhodopsin closely resemble the crystal structure.
Biochim. Biophys. Acta. 1466:1–6.
Kumar, A., R. R. Ernst, and K. Wuthrich. 1980. A two-dimensional nuclear
Overhauser enhancement (2D NOE) experiment for the elucidation of
complete proton-proton cross-relaxation networks in biological macro-
molecules. Biochem. Biophys. Res. Commun. 95:1–6.
Lomize, A. L., K. V. Pervushin, and A. S. Arseniev. 1992. Spatial structure
of (34–65)bacterioopsin polypeptide in SDS micelles determined from
nuclear magnetic resonance data. J. Biomol. NMR. 2:361–372.
Ludvigsen, S., K. V. Andersen, and F. M. Poulsen. 1991. Accurate mea-
surements of coupling constants from two-dimensional nuclear magnetic
resonance spectra of proteins and determination of phi-angles. J. Mol.
Biol. 217:731–736.
Luecke, H., B. Schobert, H.-T. Richter, J.-P. Cartailler, and J. J. K. Lanyi.
1999. Structure of bacteriorhodopsin at 1.55 angstrom resolution. J. Mol.
Biol. 291:899.
Padmanabhan, S., M. A. Jimenez, and M. Rico. 1999. Folding propensities
of synthetic peptide fragments covering the entire sequence of phage 434
Cro protein. Protein Sci. 8:1675–1688.
Palczewski, K., T. Kumasaka, T. Hori, C. A. Behnke, H. Motoshima, B. A.
Fox, I. Le Trong, D. C. Teller, T. Okada, R. E. Stenkamp, M.
Yamamoto, and M. Miyano. 2000. Crystal structure of rhodopsin: a G
protein-coupled receptor. Science. 289:739–745.
Pebay-Peyroula, E., G. Rummel, J. P. Rosenbusch, and E. M. Landau.
1997. X-ray structure of bacteriorhodopsin at 2.5 angstroms from mi-
crocrystals grown in lipidic cubic phases. Science. 277:1676–1681.
Pervushin, K. V., V. Y. Orekhov, A. I. Popov, L. Y. Musina, and A. S.
Arseniev. 1994. Three-dimensional structure of (1–71)bacterioopsin sol-
ubilized in methanol/chloroform and SDS micelles determined by
15N–1H heteronuclear NMR spectroscopy. Eur. J. Biochem. 219:
571–583.
Popot, J.-L., and D. M. Engelman. 2000. Helical membrane protein fold-
ing, stability, and evolution. Annu. Rev. Biochem. 69:881–922.
Polytopic Membrane Protein Structure 1035
Biophysical Journal 81(2) 1029–1036
Ramirez-Alvarado, R., L. Serrano, and F. J. Blanco. 1997. Conformational
analysis of peptides corresponding to all the secondary structure ele-
ments of protein L B1 domain. Protein Sci. 6:162–174.
Reymond, M. T., G. Merutka, H. J. Dyson, and P. E. Wright. 1997. Folding
propensities of peptide fragments of myoglobin. Protein Sci. 6:706–716.
Wilce, J. A., D. Salvatore, J. D. Waade, and D. J. Craik. 1999. H-1 NMR
structural studies of a cystine-linked peptide containing residues 71–93
of transthyretin and effects of a ser84 substitution implicated in familial
amyloidotic polyneuropathy. Eur. J. Biochem. 262:586–594.
Wu¨thrich, K., M. Billeter, and W. J. Braun. 1983. Pseudo-structures for the
20 common amino acids for use in studies of protein conformations by
measurements of intramolecular proton proton distance constraints with
nuclear magnetic resonance. J. Mol. Biol. 169:949–961.
Yang, A.-S., B. Hitz, and B. Honig. 1996a. Free energy determinants of
secondary structure formation:  turns and their role in protein folding.
J. Mol. Biol. 259:873–882.
Yang, K., D. L. Farrens, W. L. Hubbell, and H. G. Khorana. 1996b.
Structure and function in rhodopsin: single cysteine substitution
mutants in the cytoplasmic interhelical E-F loop region show posi-
tion-specific effects in transducin activation. Biochemistry. 35:
12464–12469.
Yeagle, P. L., J. L. Alderfer, and A. D. Albert. 1995. Structure of the
carboxyl terminal domain of bovine rhodopsin. Nat. Struct. Biol.
2:832–834.
Yeagle, P. L., J. L. Alderfer, and A. D. Albert. 1997. The first and second
cytoplasmic loops of the G-protein receptor, rhodopsin, independently
form -turns. Biochemistry. 36:3864–3869.
Yeagle, P. L., C. Danis, G. Choi, J. L. Alderfer, and A. D. Albert. 2000.
Three dimensional structure of the seventh transmembrane helical do-
main of the G-protein receptor, rhodopsin. Molecular Vision.
www.molvis.org/molvis/v 6/a17/.
1036 Katragadda et al.
Biophysical Journal 81(2) 1029–1036
